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Lymphomas of the oral cavity represent 5% of all lymphomas. They usually occur in immunocompromised patients. Lymphoma
arising within a single bone, without visceral or lymph node involvement, is known as primary intraosseous lymphoma. It is
a rare condition and constitutes 3.1% of malignant bone tumors and 5% of extranodal lymphomas. Primary lymphoma of
the jaw is seldom seen and it is often misdiagnosed. Clinically, the manifestations are usually similar to an odontogenic tumor,
cyst, or infection. Radiographically it appears as a radiolucent area that may mimic endodontic lesion, periodontal pathology, or
odontogenic cyst or tumor. The initial presentation is commonly followed by multiple unnecessary extractions and/or root canal
treatments. We present ﬁve cases of rare primary lymphoma of the maxillofacial complex, four of them intraosseous.
1.Introduction
Lymphomas are malignant neoplasms of lymphoreticular
cells.TheRevisedEuropean-AmericanLymphomaclassiﬁca-
tion, REAL/WHO system, describes three categories of lym-
phoid neoplasms based on cell lineage: B-cell malignancy,
T-cell/natural killer malignancy, and Hodgkin’s lymphoma.
Lymphomas and lymphoid leukemias are included in this
classiﬁcation, due to the fact that they are manifestation of
the same condition [1].
Non-Hodgkin’s lymphomas (NHLs), in contrast to
Hodgkin’s disease, usually manifest outside of the lymphoid
system. Skin, abdomen, lung, central nervous system, and
oral cavity are common locations [2].
The Waldeyer’s ring, located at the entrance of the res-
piratory and digestive systems, is composed by the palatine
tonsils, nasopharyngeal tonsils (adenoid), and lingual tonsils
and constitutes the most common place for NHL of the oral
cavity. Waldeyer’s ring forms part of the mucosa-associated
lymphoid tissue (MALT) and presents the ﬁrst defense line
against exogenous aggressors.
Malignant lymphomas of the oral cavity represent 5%
of all lymphomas [3] and are most common among male
patients between 50 to 70 years of age [4]. Hematologic
malignancies are very often seen in immunocompromised
patients [5].
Large B-cell lymphoma (LBCL) is the most common
non-Hodgkin’s lymphoma. LBCL is a fast growing malig-
nancy that may arise inside or outside of the lymphatic
system, usually in the gastrointestinal tract, brain, testis,
breast, skin, or thyroid.
Often the ﬁrst symptoms of large B-cell lymphoma of the
oralcavityarepainless swellingofthe neck, fever,sweats,and
weight loss.
Lymphoma arising central in a single bone, without
visceral or lymph node involvement, is known as primary
intraosseous lymphoma [4] (PIL). Primary intraosseous
lymphoma is a rare condition and constitutes 3.1% of malig-
nant bone tumors [6] and 5% of extranodal lymphomas [7].
The most common PIL is non-Hodgkin’s large cell type.
Primary intraosseous lymphoma of the jaw is seldom
seen and it is often misdiagnosed. Clinically, the manifesta-
tions are usually similar to an odontogenic tumor, cyst, or
infection. Radiographically it appears as a radiolucent area
thatmaymimicendodonticlesion,periodontalpathology,or
odontogenic cyst or tumor. This lesion shows destructive but
localized behavior. The initial wrong diagnosis is followed by
multiple extractions and/or root canal treatments.2 Case Reports in Radiology
Theimmunophenotype ofdiﬀuselargeB-celllymphoma
is variable; therefore it indicates that this comprises a
heterogeneous group of tumors. More than 25% of LBCL
have a translocation t(14;18), and most of them express bcl-
2 with or without a translocation present. Chromosomal
rearrangements aﬀecting the bcl-6 gene (regulator of ger-
minal centre formation) at 3q27 are seen in 30% of LBCL
extranodal tumors. The t(8;14) also occurs in LBCL as well
as in Burkitt’s Lymphoma. Mutations and deletion of p53 are
common in LBCL. Bcl-6 and Bcl-2 are between the strongest
predictors of survival [8].
The initial treatment for most patients is known as
CHOPR chemotherapy (cyclophosphamide, hydroxydox-
orubicin, oncovin, prednisone, and rituxan). Radiotherapy
is used in early states for massive tumors. About 45% of
patients may be cured using this protocol.
The International Prognostic Index (IPI) is based on
extent of the disease, age, and behavior of the tumor.
More than one extranodal site of disease is an indicator
of a less favorable prognosis. Most of the patients are in
an intermediate category, many of whom will be cured
by CHOPR. An extranodal origin seems to be a favorable
prognostic factor. Cell variables that may be important in
predicting outcome are bcl-2 expression, cell proliferation
rate,p53expressionandmutation,andbcl-6rearrangements
[9].
2. Report of FiveCases
PIL is an extremely rare condition. All the reported patients
were seen in the dental clinics of Nova Southeastern Uni-
versity College of Dental Medicine, between the years 2002
and 2010. NSU Dental clinics receive around 400 patients
daily. The Oral and Maxillofacial Surgery Department, Oral
and Maxillofacial Radiology Department, and Oral and
Maxillofacial Pathology Division, constitute a consultation
center for South Florida.
2.1. Case 1. A 58-year-old white man was referred to Nova
Southeastern University, Oral and Maxillofacial Surgery
Clinic for evaluation and treatment of an intraosseous
expansive radiolucent lesion of the anterior mandible. Med-
ical history showed sleep apnea and hypertension and the
only medication was antihypertensive. No known allergies.
Clinically, a painless expansion from buccal to lingual, in
the left side of the mandible, covered by normal mucosa and
hard upon palpation was noted. The teeth in the area were
displaced (Figure 1). Radiographically an osteolytic, well-
circumscribed multilocular lesion from the left molar to the
right premolar area was seen (Figure 2). Some of the teeth
in the area were nonvital, but no root canal treatments were
present. The patient did not know the time of evolution. No
palpable lymph nodes were found.
With the diﬀerential diagnosis of odontogenic kerato-
cystic tumor, ameloblastoma, other odontogenic lesions,
and central giant cell tumor, an incisional biopsy was
performed under local anesthesia. H&E sections showed a
mass composed of uniform, round, hyperchromatic cells
with large nuclei and prominent nucleoli. Increased mitotic
Figure 1: Case 1. Clinical presentation. Swelling of the mandible.
Figure 2: Case 1. Panoramic radiograph showing lytic multilocular
lesion: mandible.
activity was noted. It was diagnosed as round cell tumor
consistent with lymphoma. Flow cytometry showed Kappa
monoclonallargeBcells,CD3negative,CD5negative,CD10
negative,CD20negative,CD22positive,CD23positive,CD
45 positive, CD 56 negative, Ki67 positive, HLA Dr positive,
FMC7 negative, and Bcl-6 and Bcl-2 weakly positive. Final
diagnosis was primary intraosseous large B cell lymphoma.
The patient is under CHOPR treatment.
2.2. Case 2. An African American female, 53 years old,
presented to the NSU clinic after a recent extraction of ﬁrst
right maxillary molar. The extraction was performed due to
mobility of the tooth. Medical history was no contributory.
Expansion of lingual and buccal plates was seen in the
area no. 3. No lymphadenopathy was noted. Panoramic
radiography showed a lytic lesion in the right maxilla
(Figure 3). With the diagnosis of inﬂammatory lesion of
dental origin, an incisional biopsy was performed. Histology
and ﬂow cytometry revealed a Large B-cell lymphoma. It
was categorized as Primary intraosseous tumor. The patient
underwent CHOPR type combination chemotherapy with
very good results. Radiotherapy was subsequently performed
and she is free of tumor 12 months later.
2.3. Case 3. A 47-year-old Hispanic female patient, with
unremarkable medical history, presented to NSU for diag-
nosis of a red, 1.5 × 2.0cms, ulcerated gingival mass in the
right mandible; the teeth were freely movable. No other
lesionsneitherpalpablelymphnodesweredetectedclinically.Case Reports in Radiology 3
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Figure 3: Case 2. Lytic lesion right maxilla.
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Figure 4: Case 3. Lytic area with displaced ﬂoating tooth, right
mandible.
Radiographically: a lytic area with displaced ﬂoating tooth
around area nos. 30–32 was noted (Figure 4). With the
diagnosis of squamous cell carcinoma, an incisional biopsy
was done. Erosion of buccal and lingual cortical plates was
noted. The initial pathology reported atypical lymphocytic
inﬁltrate and nuclear dust, consistent with lymphoma. Flow
cytometry showed monoclonal Kappa B cells, CD5, CD 20,
CD22, CD23, CD 45, Ki67, and Bcl-6 and Bcl-2 positive.
The ﬁnal diagnosis was large B-cell Lymphoma. The patient
returned to her country of origin.
2.4. Case 4. A 48-year-old African American female, with no
contributorymedicalhistory,presentedtoNSUfordiagnosis
ofared,6.0×3.0cms,ulceratedpalatalmasswithdestruction
of the bone and exposed dental roots, extending to the
vestibularareaoftherightmaxilla.Theteethwerecompletely
movable. No other lesions and no palpable lymph nodes
were present. Radiographically: a radiolucent lesion with
ﬂoating right maxillary molars was noted (Figures 5 and 6).
With the diagnosis of squamous cell carcinoma versus other
malignancy, an incisional biopsy was performed. The initial
Figure5:Case4.Ulcerated,exophyticpalatalmasswithdestruction
of the bone and exposed dental roots.
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Figure 6: Case 4. Panoramic radiograph showing lytic area with
ﬂoating teeth. Maxilla.
pathologyreportdescribedatypicalroundcellinﬁltrate,con-
sistent with lymphoma. Flow cytometry showed monoclonal
Kappa B cells, CD 20, CD 45, Ki67, and Bcl-2 positive. The
ﬁnal diagnosis was large B-cell lymphoma.
2.5. Case 5. A 48-year-old male “healthy” patient presents
to the NSU clinic with slight swelling of the right maxilla
(Figure 7). The premolars had root canal treatment and the
ﬁrst molar was extracted previously. The area was tender.
No lymphadenopathy was identiﬁed. Radiographically;there
wasamixed diﬀuse pattern suggestive of ﬁbro-osseous lesion
(Figure 8). After CT Scan and immunohistochemistry, the
lesion was diagnosed as intraosseous large B-cell lymphoma.
The patient is under CHOPR treatment.
None of the patients had evidence of lymphoma in any
other area of the body.
3. Discussion
We presented ﬁve uncommon cases of large B-cell lym-
phomas, four of them primary intraosseous, in immuno-
competent patients.
Oropharyngeal lymphomas are often complication of
HIV-infected persons or immunosuppressed transplant
recipients. Hodgkin and non-Hodgkin lymphoma in AIDS4 Case Reports in Radiology
Figure 7: Case 5. Slight swelling of the maxilla.
A3
Figure 8: Case 5. Periapical radiograph.
patientsmayappearevenunderpotentantiretroviraltherapy
(2% of oral neoplasms in AIDS patients) [10]. How-
ever, non-immunosuppressed patients of any age can be
also aﬀected. Most immunocompetent patients with non-
Hodgking lymphoma of the gnathic region are middle aged
males.Lymphomasofthisarearepresent2%ofallextranodal
lymphomasandcanaﬀectbothboneandsoftoraltissuewith
the most frequent localization being the Waldeyer’s ring.
Large B-cell lymphoma (LBCL) is the most common
type of non-Hogdkin’s lymphoma, and it may arise inside
or outside the lymphatic system. Often the ﬁrst symptoms
of a large B-cell lymphoma of the oral cavity are a painless
swelling, a nonhealing ulcer, fever, sweats, and weight loss.
A nonpainful lymph node enlargement and a submucosal
lesion in the junction between hard and soft palate are highly
suspicious. Often, the oral manifestations are secondary
to a more widespread involvement. Primary lymphoma of
the oral cavity is not common and primary intraosseous
lymphomaintheheadareaisevenrarerandconstitutes3.1%
of malignant bone tumors [6].
Soft tissue lymphoma of the oral cavity and primary
lymphoma of the jaw are often misdiagnosed. Clinically
and radiographically, the manifestation is usually similar to
squamous cell carcinoma or to an odontogenic tumor, cyst,
or infection.
The initial treatment for most patients is combination of
chemotherapeutic drugs. Radiotherapy is used in early states
for massive tumors.
Early diagnosis will improve the prognosis. However,
patients older than 60, stages 3 or 4 and several extranodal
places of involvement, will have a nonfavorable prognosis.
Theinitialresponsetotreatmentisgoodbutthisentityshows
a prolonged course with remissions and exacerbations. The
disease may progress into a leukemia.
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